Skip to main navigation Skip to search Skip to main content

Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial)

  • Silja K. Majahalme
  • , Lawrence Baruch
  • , Nora Aknay
  • , Liselotte Goedel-Meinen
  • , Monika Hofmann
  • , Allen Hester
  • , Margaret Forney Prescott
  • , Nancy Feliciano

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Abstract

The comparison of treatment effect and co-morbidity between the genders in the Valsartan Heart Failure Trial showed equal benefit of treatment in men and women. Co-morbidities, such as diabetes and coronary artery disease, increased nonfatal cardiac morbidity more in women than in men.

Original languageEnglish
Pages (from-to)529-532
Number of pages4
JournalAmerican Journal of Cardiology
Volume95
Issue number4
DOIs
StatePublished - 15 Feb 2005

Fingerprint

Dive into the research topics of 'Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial)'. Together they form a unique fingerprint.

Cite this